EssilorLuxottica Operating Expenses 2011-2024 | ESLOY

EssilorLuxottica operating expenses for the twelve months ending December 31, 2024 were $0M, a 0% increase year-over-year.

  • EssilorLuxottica annual operating expenses for 2024 were $24.953B, a 3.77% increase from 2023.
  • EssilorLuxottica annual operating expenses for 2023 were $24.047B, a 6.97% increase from 2022.
  • EssilorLuxottica annual operating expenses for 2022 were $22.48B, a 8.61% increase from 2021.

EssilorLuxottica Operating Expenses 2011-2024 | ESLOY

  • EssilorLuxottica annual operating expenses for 2024 were $24.953B, a 3.77% increase from 2023.
  • EssilorLuxottica annual operating expenses for 2023 were $24.047B, a 6.97% increase from 2022.
  • EssilorLuxottica annual operating expenses for 2022 were $22.48B, a 8.61% increase from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$220.2B
Boston Scientific (BSX)$157B
Stryker (SYK)$154B
Medtronic (MDT)$119.2B
Lonza Group Ag (LZAGY)$50.3B
Haleon (HLN)$44.4B
ResMed (RMD)$40.3B
GE HealthCare Technologies (GEHC)$35.5B
Agilent Technologies (A)$34.1B
Terumo (TRUMY)$25.8B
Koninklijke Philips (PHG)$25.2B
Insulet (PODD)$20.4B
Zimmer Biomet Holdings (ZBH)$19.3B
Baxter (BAX)$15B
Smith & Nephew SNATS (SNN)$13.9B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Bio-Rad Laboratories (BIO)$7.2B
Lantheus Holdings (LNTH)$5B
Perrigo (PRGO)$3.9B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.2B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.9B
AtriCure (ATRC)$1.6B
Acuren (TIC)$1.4B
Green Thumb Industries (GTBIF)$1.3B